An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practice

Journal of Evaluation in Clinical Practice

Volumn 12, Issue 6, 2006, Pages 613-621

  Kasje, Willeke N ^b   Denig, Petra ^a,b   Stewart, Roy E ^b   De Graeff, Pieter A ^b,c   Haaijer Ruskamp, Flora M ^b  

^a Department of Clinical Pharmacology ^*  (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Doctor's practice patterns; Family practice education; Guideline adherence; Health care; Peer review

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FOSINOPRIL; INSULIN; LISINOPRIL; NITRATE; ORAL ANTIDIABETIC AGENT; PERINDOPRIL; RAMIPRIL; SPIRONOLACTONE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION PROGRAM; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PEER REVIEW; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; EDUCATION, MEDICAL, CONTINUING; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PEER REVIEW; PROGRAM EVALUATION; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 33750798495     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2005.00625.x     Document Type: Article

References (25)

1. Berlowitz D.R., Ash A.S., Hickey E.C., Glickman M., Friedman R. & Kader B. (2003) Hypertension management in patients with diabetes: the need for more aggressive therapy. Diabetes Care 26 (2), 355-359.
2. Beyer M., Gerlach F.M., Flies U., Grol R., Krol Z., Munck A., Olesen F., O'Riordan M., Seuntjes L. & Szecsenyi J. (2003) The development of quality circles/peer review groups as a method of quality improvement in Europe: results of a survey in 26 European countries. Family Practice 20 (4), 443-451.
3. Cleland J.G., Cohen-Solal A., Aguilar J.C. et al. (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programmeme): an international survey. Lancet 360 (9346), 1631-1639.
4. CVZ (National Health Insurance Board). (2003) Desk Reference Book (Farmocotherapeutisch Kompas). CVZ, Utrecht.
5. De Groot J. & Cambach W. (2003) Peer review groups; more than noncommittal (De vrijblijvendheid voorbij. Farmacotherapiegroepen kunnen beter functioneren). Medisch Contact 38 (3), 102-104.
6. Flottorp S., Havelsrud K. & Oxman A. (2003) Process evaluation of a cluster randomized trial of tailored interventions to implement guidelines in primary care - why is it so hard to change practice? Family Practice 20 (3), 333-339.
7. Gilbody S., Whitty P., Grimshaw J. & Thomas R.E. (2003) Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA 289, 3145-3151.
8. Grant R.W., Hamrick H.E., Sullivan C.M., Dubey A.K., Chueh H.C., Cagliero E. & Meigs J.B. (2003) Impact of population management with direct physician feedback on care of patients with type 2 diabetes. Diabetes Care 26 (8), 2275-2280.
9. Grimshaw J.M., Thomas R.E., MacLennan G. (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technology Assessment 8 (6), iii-iv, 1-72.
10. Grol R. (2001) Successes and failures in the implementation of evidence-based guidelines for clinical practice. Medical Care 39 (8), II46-II54.
11. Kasje W.N., Denig P., de Graeff P.A. & Haaijer-Ruskamp F.M. (2004) Physicians' views on joint treatment guidelines for primary and secondary care. International Journal for Quality in Health Care 16 (3), 229-236.
12. Kasje W.N., Denig P., Stewart R.E., de Graeff P.A. & Haaijer-Ruskamp F.M. (2005) Physician, organizational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure: a multilevel study. European Journal of Clinical Pharmacology 61 (3), 145-151.
13. Kvamme O.J., Olesen F. & Samuelsson M. (2001) Improving the interface between primary and secondary care: a statement from the European working party on quality in family practice (EQuiP). Quality in Health Care 10, 33-39.
14. Luzier A.B., Forrest A., Adelman M., Hawari F.I., Schentag J.J. & Izzo J.L. Jr (1998) Impact of angiotensinconverting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure. American Journal of Cardiology 82 (4), 465-469.
15. Madridejos-Mora R., Amado-Guirado E. & Perez-Rodriguez M.T. (2004) Effectiveness of the combination of feedback and educational recommendations for improving drug prescription in general practice. Medical Care 42 (7), 643-648.
16. Pont L.G., Sturkenboom M.C., Van Gilst W.H., Denig P. & Haaijer-Ruskamp F.M. (2003) Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000. Pharmacoepidemiology and Drug Safety 12 (4), 327-334.
17. Proeftuin Farmaceutische Zorg. (2000) The Groningen Transmural Guidelines ('Op weg naar het Groninger transmuraal formularium'). 1 ed. Groningen.
18. Schaars C.F., Denig P., Kasje W.N., Stewart R.E., Wolffenbuttel B.H.R. & Haaijer-Ruskamp F.M. (2004) Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care. Diabetes Care 27 (1), 123-128.
19. Smeele I.J., Grol R.P., van Schayck C.P., van den Bosch W.J., van den Hoogen H.J. & Muris J.W. (1999) Can small group education and peer review improve care for patients with asthma/chronic obstructive pulmonary disease? Quality in Health Care 8 (2), 92-98.
20. Snijders T. & Bosker R. (2002) Multilevel analysis. An Introduction to Basic and Advanced Multilevel Modeling. SAGE, London.
21. UKPDS 38. UK Prospective Diabetes Study Group. (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. British Medical Journal 317 (7160), 703-713.
22. Van Dijk L., Barnhoorn H. & De Bakker D. (1999) Peer Review Groups on Pharmacotheray in 1999 (In Dutch: Het Farmaco Therapie Overleg in 1999). NIVEL, Utrecht.
23. Van Eijk M.E., Avorn J., Porsius A.J. & de Boer A. (2001) Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. British Medical Journal 322 (7287), 654-657.
24. Veninga C.C., Denig P., Zwaagstra R. & Haaijer-Ruskamp F.M. (2000) Improving drug treatment in general practice. Journal of Clinical Epidemiology 53 (7), 762-772.
25. Veninga C.C., Lagerlov P., Wahlstrom R., Muskova M., Denig P., Berkhof J., Kochen M.M. & Haaijer-Ruskamp F.M. (1999) Evaluating an educational intervention to improve the treatment of asthma in four European countries. Drug Education Project Group. American Journal of Respiratory and Critical Care Medicine 160 (4), 1254-1262.